<!DOCTYPE html><html lang="en-us" >

<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  
  
  
  <meta name="generator" content="Wowchemy 5.0.0-beta.0 for Hugo">
  

  

  
  

  
  
  
  
  
    
    
    
  
  

  <meta name="author" content="Chandrika B-Rao">

  
  
  
    
  
  <meta name="description" content="Metabolic syndrome is a widely prevalent multifactorial disorder associated with an increased risk of cardiovascular disease and type 2 diabetes mellitus. High plasma levels of insulin and glucose due to insulin resistance are a major component of the metabolic disorder. Thiazolidinediones (TZDs) are potent PPARγ ligand and used as insulin sensitizers in the treatment of type 2 diabetes mellitus. They are potent insulin-sensitizing agents but due to adverse effects like hepatotoxicity, a safer alternative of TZDs is highly demanded. Here we report synthesis of N-(6-(4-(piperazin-1-yl)phenoxy)pyridin-3-yl)benzenesulfonamide derivatives as an alternate remedy for insulin resistance.">

  
  <link rel="alternate" hreflang="en-us" href="https://sukrutrao.github.io/cbr-website-output/publication/synthesis-of-n-6-4-piperazin-1-yl-phenoxy-pyridin-3-yl-benzenesulfonamide-derivatives-for-the-treatment-of-metabolic-syndrome/">

  







  




  
  
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  

  
  
  
  <meta name="theme-color" content="#2962ff">
  

  
  
  
  <script src="/cbr-website-output/js/mathjax-config.js"></script>
  

  
  
  
  
    
    
      <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.9.0/css/academicons.min.css" integrity="sha512-W4yqoT1+8NLkinBLBZko+dFB2ZbHsYLDdr50VElllRcNt2Q4/GSs6u71UHKxB7S6JEMCp5Ve4xjh3eGQl/HRvg==" crossorigin="anonymous">
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.14.0/css/all.min.css" integrity="sha256-FMvZuGapsJLjouA6k7Eo2lusoAX9i0ShlWFG6qt7SLc=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.5.7/jquery.fancybox.min.css" integrity="sha256-Vzbj7sDDS/woiFS3uNKo8eIuni59rjyNGtXfstRzStA=" crossorigin="anonymous">

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.2.0/styles/github.min.css" crossorigin="anonymous" title="hl-light">
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.2.0/styles/dracula.min.css" crossorigin="anonymous" title="hl-dark" disabled>
        
      
    

    

    

    
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
        <script src="https://cdnjs.cloudflare.com/ajax/libs/lazysizes/5.2.2/lazysizes.min.js" integrity="sha512-TmDwFLhg3UA4ZG0Eb4MIyT1O1Mb+Oww5kFG0uHqXsdbyZz9DcvYQhKpGgNkamAI6h2lGGZq2X8ftOJvF/XjTUg==" crossorigin="anonymous" async></script>
      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
        <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml.js" integrity="" crossorigin="anonymous" async></script>
      
    
      

      
      

      
    
      

      
      

      
    

  

  
  
  
    
      
      
      <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,700%7CRoboto+Mono%7CLato:400,700%7COpen+Sans&display=swap">
    
  

  
  
  
  
  <link rel="stylesheet" href="/cbr-website-output/css/wowchemy.css">

  




  

  


  
  

  

  <link rel="manifest" href="/cbr-website-output/index.webmanifest">
  <link rel="icon" type="image/png" href="/cbr-website-output/images/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_32x32_fill_lanczos_center_2.png">
  <link rel="apple-touch-icon" type="image/png" href="/cbr-website-output/images/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_192x192_fill_lanczos_center_2.png">

  <link rel="canonical" href="https://sukrutrao.github.io/cbr-website-output/publication/synthesis-of-n-6-4-piperazin-1-yl-phenoxy-pyridin-3-yl-benzenesulfonamide-derivatives-for-the-treatment-of-metabolic-syndrome/">

  
  
  
  
  
  
  
    
    
  
  
  <meta property="twitter:card" content="summary">
  
  <meta property="og:site_name" content="Chandrika B-Rao">
  <meta property="og:url" content="https://sukrutrao.github.io/cbr-website-output/publication/synthesis-of-n-6-4-piperazin-1-yl-phenoxy-pyridin-3-yl-benzenesulfonamide-derivatives-for-the-treatment-of-metabolic-syndrome/">
  <meta property="og:title" content="Synthesis of N-(6-(4-(Piperazin-1-yl)phenoxy)pyridin-3-yl)benzenesulfonamide Derivatives for the Treatment of Metabolic Syndrome | Chandrika B-Rao">
  <meta property="og:description" content="Metabolic syndrome is a widely prevalent multifactorial disorder associated with an increased risk of cardiovascular disease and type 2 diabetes mellitus. High plasma levels of insulin and glucose due to insulin resistance are a major component of the metabolic disorder. Thiazolidinediones (TZDs) are potent PPARγ ligand and used as insulin sensitizers in the treatment of type 2 diabetes mellitus. They are potent insulin-sensitizing agents but due to adverse effects like hepatotoxicity, a safer alternative of TZDs is highly demanded. Here we report synthesis of N-(6-(4-(piperazin-1-yl)phenoxy)pyridin-3-yl)benzenesulfonamide derivatives as an alternate remedy for insulin resistance."><meta property="og:image" content="https://sukrutrao.github.io/cbr-website-output/images/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_512x512_fill_lanczos_center_2.png">
  <meta property="twitter:image" content="https://sukrutrao.github.io/cbr-website-output/images/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_512x512_fill_lanczos_center_2.png"><meta property="og:locale" content="en-us">
  
    
      <meta property="article:published_time" content="2020-11-18T22:23:23&#43;01:00">
    
    <meta property="article:modified_time" content="2020-11-18T23:13:02&#43;01:00">
  

  


    









<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Article",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://sukrutrao.github.io/cbr-website-output/publication/synthesis-of-n-6-4-piperazin-1-yl-phenoxy-pyridin-3-yl-benzenesulfonamide-derivatives-for-the-treatment-of-metabolic-syndrome/"
  },
  "headline": "Synthesis of N-(6-(4-(Piperazin-1-yl)phenoxy)pyridin-3-yl)benzenesulfonamide Derivatives for the Treatment of Metabolic Syndrome",
  
  "datePublished": "2020-11-18T22:23:23+01:00",
  "dateModified": "2020-11-18T23:13:02+01:00",
  
  "author": {
    "@type": "Person",
    "name": "Nabajyoti Deka"
  },
  
  "publisher": {
    "@type": "Organization",
    "name": "Chandrika B-Rao",
    "logo": {
      "@type": "ImageObject",
      "url": "https://sukrutrao.github.io/cbr-website-output/images/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_192x192_fill_lanczos_center_2.png"
    }
  },
  "description": "Metabolic syndrome is a widely prevalent multifactorial disorder associated with an increased risk of cardiovascular disease and type 2 diabetes mellitus. High plasma levels of insulin and glucose due to insulin resistance are a major component of the metabolic disorder. Thiazolidinediones (TZDs) are potent PPARγ ligand and used as insulin sensitizers in the treatment of type 2 diabetes mellitus. They are potent insulin-sensitizing agents but due to adverse effects like hepatotoxicity, a safer alternative of TZDs is highly demanded. Here we report synthesis of N-(6-(4-(piperazin-1-yl)phenoxy)pyridin-3-yl)benzenesulfonamide derivatives as an alternate remedy for insulin resistance."
}
</script>

  

  


  


  





  <title>Synthesis of N-(6-(4-(Piperazin-1-yl)phenoxy)pyridin-3-yl)benzenesulfonamide Derivatives for the Treatment of Metabolic Syndrome | Chandrika B-Rao</title>

</head>


<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" class="page-wrapper  ">

  
  
  
    <script>window.wcDarkLightEnabled = true;</script>
  
  
    <script>const isSiteThemeDark = false;</script>
  
  
  <script src="/cbr-website-output/js/load-theme.js"></script>

  <aside class="search-results" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        <input name="q" id="search-query" placeholder="Search..." autocapitalize="off"
        autocomplete="off" autocorrect="off" spellcheck="false" type="search" class="form-control">
        
      </div>

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>


  <div class="page-header">
    












<nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id="navbar-main">
  <div class="container">

    
    <div class="d-none d-lg-inline-flex">
      <a class="navbar-brand" href="/cbr-website-output/">Chandrika B-Rao</a>
    </div>
    

    
    <button type="button" class="navbar-toggler" data-toggle="collapse"
            data-target="#navbar-content" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
    <span><i class="fas fa-bars"></i></span>
    </button>
    

    
    <div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
      <a class="navbar-brand" href="/cbr-website-output/">Chandrika B-Rao</a>
    </div>
    

    
    
    <div class="navbar-collapse main-menu-item collapse justify-content-start" id="navbar-content">

      
      <ul class="navbar-nav d-md-inline-flex">
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
            
            
            
              
            
            
          
        

        <li class="nav-item">
          <a class="nav-link " href="/cbr-website-output/#about"><span>Home</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
            
            
            
              
            
            
          
        

        <li class="nav-item">
          <a class="nav-link " href="/cbr-website-output/#publications"><span>Publications</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
            
            
            
              
            
            
          
        

        <li class="nav-item">
          <a class="nav-link " href="/cbr-website-output/#talks"><span>Talks</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
            
            
            
              
            
            
          
        

        <li class="nav-item">
          <a class="nav-link " href="/cbr-website-output/#experience"><span>Experience</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
            
            
            
              
            
            
          
        

        <li class="nav-item">
          <a class="nav-link " href="/cbr-website-output/#awards"><span>Awards</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
            
            
            
              
            
            
          
        

        <li class="nav-item">
          <a class="nav-link " href="/cbr-website-output/#contact"><span>Contact</span></a>
        </li>

        
        

      

        
      </ul>
    </div>

    <ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">
      
      
      <li class="nav-item">
        <a class="nav-link js-search" href="#" aria-label="Search"><i class="fas fa-search" aria-hidden="true"></i></a>
      </li>
      

      
      
      <li class="nav-item dropdown theme-dropdown">
        <a href="#" class="nav-link" data-toggle="dropdown" aria-haspopup="true">
          <i class="fas fa-moon" aria-hidden="true"></i>
        </a>
        <div class="dropdown-menu">
          <a href="#" class="dropdown-item js-set-theme-light">
            <span>Light</span>
          </a>
          <a href="#" class="dropdown-item js-set-theme-dark">
            <span>Dark</span>
          </a>
          <a href="#" class="dropdown-item js-set-theme-auto">
            <span>Automatic</span>
          </a>
        </div>
      </li>
      

      

    </ul>

  </div>
</nav>


  </div>

  <div class="page-body">
    <div class="pub">

  












  

  
  
  
<div class="article-container pt-3">
  <h1>Synthesis of N-(6-(4-(Piperazin-1-yl)phenoxy)pyridin-3-yl)benzenesulfonamide Derivatives for the Treatment of Metabolic Syndrome</h1>

  

  
    


<div class="article-metadata">

  
  
  
  
  <div>
    

  
  <span >Nabajyoti Deka</span>, <span >Swapnil Bajare</span>, <span >Jessy Anthony</span>, <span >Amrutha Nair</span>, <span >Anagha Damre</span>, <span >Dharmeshkumar Patel</span>, <span class="author-highlighted">Chandrika B-Rao</span>, <span >H. Sivaramakrishnan</span>, <span >Shivaprakash Jagalur Mutt</span>, <span >Chandan Wilankarc</span>, <span >Rosalind Marita</span>
  </div>
  
  

  
  <span class="article-date">
    
    
      
    
    December 2013
  </span>
  

  

  

  
  
  
  
  

  
  

</div>

    











  



<div class="btn-links mb-3">
  
  








  





<button type="button" class="btn btn-outline-primary my-1 mr-1 js-cite-modal"
        data-filename="/cbr-website-output/publication/synthesis-of-n-6-4-piperazin-1-yl-phenoxy-pyridin-3-yl-benzenesulfonamide-derivatives-for-the-treatment-of-metabolic-syndrome/cite.bib">
  Cite
</button>













<a class="btn btn-outline-primary my-1 mr-1" href="https://doi.org/10.1155/2013/201580" target="_blank" rel="noopener">
  DOI
</a>


  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary my-1 mr-1" href="https://www.researchgate.net/profile/Dharmeshkumar_Patel2/publication/258342273_Synthesis_of_N-6-4-Piperazin-1-ylphenoxypyridin-3-ylbenzenesulfonamide_Derivatives_for_the_Treatment_of_Metabolic_Syndrome/links/00463527f5b1c57d45000000/Synthesis-of-N-6-4-Piperazin-1-ylphenoxypyridin-3-ylbenzenesulfonamide-Derivatives-for-the-Treatment-of-Metabolic-Syndrome.pdf" target="_blank" rel="noopener">
    <i class="fas fa-file-pdf mr-1"></i>
    Paper
  </a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary my-1 mr-1" href="https://www.hindawi.com/journals/ijmc/2013/201580/" target="_blank" rel="noopener">
    <i class="fas fa-globe mr-1"></i>
    Publisher Link
  </a>


</div>


  
</div>



  <div class="article-container">

    
    <h3>Abstract</h3>
    <p class="pub-abstract">Metabolic syndrome is a widely prevalent multifactorial disorder associated with an increased risk of cardiovascular disease and type 2 diabetes mellitus. High plasma levels of insulin and glucose due to insulin resistance are a major component of the metabolic disorder. Thiazolidinediones (TZDs) are potent PPARγ ligand and used as insulin sensitizers in the treatment of type 2 diabetes mellitus. They are potent insulin-sensitizing agents but due to adverse effects like hepatotoxicity, a safer alternative of TZDs is highly demanded. Here we report synthesis of N-(6-(4-(piperazin-1-yl)phenoxy)pyridin-3-yl)benzenesulfonamide derivatives as an alternate remedy for insulin resistance.</p>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            
            
            <a href="/cbr-website-output/publication/#2">
              Journal article
            </a>
            
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Publication</div>
          <div class="col-12 col-md-9">International Journal of Medicinal Chemistry, vol. 2013, Article ID 201580</div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    <div class="space-below"></div>

    <div class="article-style"></div>

    






<div class="article-tags">
  
  <a class="badge badge-light" href="/cbr-website-output/tag/drug-discovery/">drug-discovery</a>
  
  <a class="badge badge-light" href="/cbr-website-output/tag/diabetes/">diabetes</a>
  
  <a class="badge badge-light" href="/cbr-website-output/tag/anti-diabetic/">anti-diabetic</a>
  
</div>



<div class="share-box" aria-hidden="true">
  <ul class="share">
    
      
      
      
        
      
      
      
      <li>
        <a href="https://twitter.com/intent/tweet?url=https://sukrutrao.github.io/cbr-website-output/publication/synthesis-of-n-6-4-piperazin-1-yl-phenoxy-pyridin-3-yl-benzenesulfonamide-derivatives-for-the-treatment-of-metabolic-syndrome/&amp;text=Synthesis%20of%20N-%286-%284-%28Piperazin-1-yl%29phenoxy%29pyridin-3-yl%29benzenesulfonamide%20Derivatives%20for%20the%20Treatment%20of%20Metabolic%20Syndrome" target="_blank" rel="noopener" class="share-btn-twitter">
          <i class="fab fa-twitter"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.facebook.com/sharer.php?u=https://sukrutrao.github.io/cbr-website-output/publication/synthesis-of-n-6-4-piperazin-1-yl-phenoxy-pyridin-3-yl-benzenesulfonamide-derivatives-for-the-treatment-of-metabolic-syndrome/&amp;t=Synthesis%20of%20N-%286-%284-%28Piperazin-1-yl%29phenoxy%29pyridin-3-yl%29benzenesulfonamide%20Derivatives%20for%20the%20Treatment%20of%20Metabolic%20Syndrome" target="_blank" rel="noopener" class="share-btn-facebook">
          <i class="fab fa-facebook"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="mailto:?subject=Synthesis%20of%20N-%286-%284-%28Piperazin-1-yl%29phenoxy%29pyridin-3-yl%29benzenesulfonamide%20Derivatives%20for%20the%20Treatment%20of%20Metabolic%20Syndrome&amp;body=https://sukrutrao.github.io/cbr-website-output/publication/synthesis-of-n-6-4-piperazin-1-yl-phenoxy-pyridin-3-yl-benzenesulfonamide-derivatives-for-the-treatment-of-metabolic-syndrome/" target="_blank" rel="noopener" class="share-btn-email">
          <i class="fas fa-envelope"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.linkedin.com/shareArticle?url=https://sukrutrao.github.io/cbr-website-output/publication/synthesis-of-n-6-4-piperazin-1-yl-phenoxy-pyridin-3-yl-benzenesulfonamide-derivatives-for-the-treatment-of-metabolic-syndrome/&amp;title=Synthesis%20of%20N-%286-%284-%28Piperazin-1-yl%29phenoxy%29pyridin-3-yl%29benzenesulfonamide%20Derivatives%20for%20the%20Treatment%20of%20Metabolic%20Syndrome" target="_blank" rel="noopener" class="share-btn-linkedin">
          <i class="fab fa-linkedin-in"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="whatsapp://send?text=Synthesis%20of%20N-%286-%284-%28Piperazin-1-yl%29phenoxy%29pyridin-3-yl%29benzenesulfonamide%20Derivatives%20for%20the%20Treatment%20of%20Metabolic%20Syndrome%20https://sukrutrao.github.io/cbr-website-output/publication/synthesis-of-n-6-4-piperazin-1-yl-phenoxy-pyridin-3-yl-benzenesulfonamide-derivatives-for-the-treatment-of-metabolic-syndrome/" target="_blank" rel="noopener" class="share-btn-whatsapp">
          <i class="fab fa-whatsapp"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://service.weibo.com/share/share.php?url=https://sukrutrao.github.io/cbr-website-output/publication/synthesis-of-n-6-4-piperazin-1-yl-phenoxy-pyridin-3-yl-benzenesulfonamide-derivatives-for-the-treatment-of-metabolic-syndrome/&amp;title=Synthesis%20of%20N-%286-%284-%28Piperazin-1-yl%29phenoxy%29pyridin-3-yl%29benzenesulfonamide%20Derivatives%20for%20the%20Treatment%20of%20Metabolic%20Syndrome" target="_blank" rel="noopener" class="share-btn-weibo">
          <i class="fab fa-weibo"></i>
        </a>
      </li>
    
  </ul>
</div>











  
  
    




  
    




  
    




  
    




  
    




  
    




  
    



  
  
  
    
  
  
  
  <div class="media author-card content-widget-hr">
    
      
      <a href="https://sukrutrao.github.io/cbr-website-output/"><img class="avatar mr-3 avatar-circle" src="/cbr-website-output/author/chandrika-b-rao/avatar_hudcb1b9efe75f3437dda98785064dc1d9_5325_270x270_fill_q75_lanczos_center.jpg" alt="Chandrika B-Rao"></a>
    

    <div class="media-body">
      <h5 class="card-title"><a href="https://sukrutrao.github.io/cbr-website-output/">Chandrika B-Rao</a></h5>
      <h6 class="card-subtitle">Independent Consultant</h6>
      <p class="card-text">Independent Consultant, Drug Discovery, Bioinformatics and Statistics</p>
      <ul class="network-icon" aria-hidden="true">
  
    
    
    
      
    
    
    
    
    
      
    
    <li>
      <a href="/cbr-website-output/#contact" >
        <i class="fas fa-envelope"></i>
      </a>
    </li>
  
    
    
    
      
    
    
    
    
    
      
    
    <li>
      <a href="https://www.researchgate.net/profile/Chandrika_B-Rao" target="_blank" rel="noopener">
        <i class="fab fa-researchgate"></i>
      </a>
    </li>
  
    
    
    
      
    
    
    
    
    
      
    
    <li>
      <a href="https://www.linkedin.com/in/chandrika-b-rao-a5574b11/" target="_blank" rel="noopener">
        <i class="fab fa-linkedin"></i>
      </a>
    </li>
  
    
    
    
    
    
    
    
      
    
    <li>
      <a href="https://orcid.org/0000-0003-3848-7945" target="_blank" rel="noopener">
        <i class="ai ai-orcid"></i>
      </a>
    </li>
  
    
    
    
    
    
    
    
      
    
    <li>
      <a href="/cbr-website-output/files/cv.pdf" >
        <i class="ai ai-cv"></i>
      </a>
    </li>
  
</ul>

    </div>
  </div>


  
    




  
    




  
    




  
    




  














  
  
  <div class="article-widget content-widget-hr">
    <h3>Related</h3>
    <ul>
      
      <li><a href="/cbr-website-output/publication/design-and-synthesis-of-non-tzd-peroxisome-proliferator-activated-receptor-gamma-ppar-gamma-modulator/">Design and synthesis of non-TZD peroxisome proliferator-activated receptor γ (PPARγ) modulator</a></li>
      
      <li><a href="/cbr-website-output/publication/lead-optimization-of-isocytosine-derived-xanthine-oxidase-inhibitors/">Lead Optimization of Isocytosine Derived Xanthine Oxidase Inhibitors</a></li>
      
      <li><a href="/cbr-website-output/publication/cyclopentyl-pyrimidine-based-analogues-as-novel-and-potent-igf-1r-inhibitor/">Cyclopentyl-pyrimidine based analogues as novel and potent IGF-1R inhibitor</a></li>
      
      <li><a href="/cbr-website-output/publication/insulin-like-growth-factor-1-receptor-inhibitors/">Insulin-like Growth Factor-1 Receptor Inhibitors</a></li>
      
      <li><a href="/cbr-website-output/talk/an-application-of-computer-aided-drug-design-for-xanthine-oxidase-inhibition/">An Application of Computer Aided Drug Design for Xanthine Oxidase Inhibition</a></li>
      
    </ul>
  </div>
  





  </div>
</div>
  </div>

  <div class="page-footer">
    
    
    <div class="container">
      <footer class="site-footer">
  

  <p class="powered-by">
    © 2020 Chandrika B-Rao
  </p>

  
  






  <p class="powered-by">
    
    
    
    Published with
    <a href="https://wowchemy.com" target="_blank" rel="noopener">Wowchemy</a>  —
    the free, <a href="https://github.com/wowchemy/wowchemy-hugo-modules" target="_blank" rel="noopener">
    open source</a> website builder that empowers creators.
    
  </p>
</footer>

    </div>
    
  </div>

  
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

      

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.5.1/jquery.min.js" integrity="sha256-9/aliU8dGd2tb6OSsuzixeV4y/faTqgFtohetphbbj0=" crossorigin="anonymous"></script>

      
      
        <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js" integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin="anonymous"></script>
        <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js" integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin="anonymous"></script>
      

      <script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.5.7/jquery.fancybox.min.js" integrity="sha256-yt2kYMy0w8AbtF89WXb2P1rfjcP/HTHLT7097U8Y5b8=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/instant.page/5.1.0/instantpage.min.js" integrity="sha512-1+qUtKoh9XZW7j+6LhRMAyOrgSQKenQ4mluTR+cvxXjP1Z54RxZuzstR/H9kgPXQsVB8IW7DMDFUJpzLjvhGSQ==" crossorigin="anonymous"></script>

      

      
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.2.0/highlight.min.js" integrity="sha512-TDKKr+IvoqZnPzc3l35hdjpHD0m+b2EC2SrLEgKDRWpxf2rFCxemkgvJ5kfU48ip+Y+m2XVKyOCD85ybtlZDmw==" crossorigin="anonymous"></script>
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.2.0/languages/r.min.js"></script>
        
      

    

    
    

    
    
    <script>const code_highlighting = true;</script>
    

    
    
    
    
    
    
    <script>
      const search_config = {"indexURI":"/cbr-website-output/index.json","minLength":1,"threshold":0.3};
      const i18n = {"no_results":"No results found","placeholder":"Search...","results":"results found"};
      const content_type = {
        'post': "Posts",
        'project': "Projects",
        'publication' : "Publications",
        'talk' : "Talks",
        'slides' : "Slides"
        };
    </script>
    

    
    

    
    
    <script id="search-hit-fuse-template" type="text/x-template">
      <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
      </div>
    </script>
    

    
    
    <script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/3.2.1/fuse.min.js" integrity="sha256-VzgmKYmhsGNNN4Ph1kMW+BjoYJM2jV5i4IlFoeZA9XI=" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/jquery.mark.min.js" integrity="sha256-4HLtjeVgH0eIB3aZ9mLYF6E8oU5chNdjU6p6rrXpl9U=" crossorigin="anonymous"></script>
    

    
    

    
    
    

    
    

    
    

    
    
    
    
    
    
    
    
    
      
    
    
    
    
    <script src="/cbr-website-output/js/wowchemy.min.d9d80f811e95b4b4f6df1eaaf297b05f.js"></script>

    






</body>
</html>
